Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn’s disease and ulcerative colitis

被引：0
|
作者：
Diana Lacruz-Guzmán
Daniel Torres-Moreno
Francisco Pedrero
Patricia Romero-Cara
Iván García-Tercero
Javier Trujillo-Santos
Pablo Conesa-Zamora
机构：
[1] Santa Lucía General University Hospital (HGUSL),Pharmacy Department
[2] HGUSL,Molecular Pathology and Pharmacogenetics Group FFIS011, Pathology Department
[3] HGUSL,Day Hospital
[4] HUGSL,Gastroenterology Department
[5] HUGSL,Internal Medicine
来源：
European Journal of Clinical Pharmacology | 2013年 / 69卷
关键词：
Tumour necrosis factor; Interleukin-1; Infliximab; Crohn’s disease; Pharmacogenetics; Ulcerative colitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 438
页数：7
相关论文
共 50 条
  • [31] Higher Rates of Dose Optimisation for Infliximab Responders in Ulcerative Colitis than in Crohn's disease
    O'Donnell, Sarah
    Stempak, Joanne M.
    Steinhart, A. Hillary
    Silverberg, Mark S.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (10): : 830 - 836
  • [32] Outcome of treat to target strategy in paediatric patients with Crohn's disease and ulcerative colitis on infliximab
    Yerlioglu, D.
    Cococcioni, L.
    ElZein, A.
    Sider, S.
    Chadokufa, S.
    Buckingham, R.
    Shah, N.
    Ocholi, A.
    Borrelli, O.
    Kiparissi, F.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S305 - S305
  • [33] Mannan-binding lectin gene polymorphisms in ulcerative colitis and Crohn's disease
    Rector, A
    Lemey, P
    Laffut, W
    Keyaerts, E
    Struyf, F
    Wollants, E
    Vermeire, S
    Rutgeerts, P
    Van Ranst, M
    GASTROENTEROLOGY, 2001, 120 (05) : A459 - A459
  • [34] Infliximab treatment decreases serum osteoprotegerin concentration in patients with Crohn's disease
    Miheller, Pal
    Muzes, Gyorgyi
    Racz, Karoly
    Blazovits, Anna
    Lakatos, Peter
    Herszenyi, Laszlo
    Tulassay, Zsolt
    GASTROENTEROLOGY, 2007, 132 (04) : A364 - A364
  • [35] IDENTIFICATION OF GENETIC POLYMORPHISMS ASSOCIATED WITH SUSTAINED RESPONSE TO INFLIXIMAB IN CROHN'S DISEASE
    Salvador-Martin, S.
    Garcia, M., I
    Blanco, C.
    Menchen, L. A.
    Marin, I
    Lopez, B.
    Nunez, O.
    Lobato, E.
    Sanjurjo, M.
    Lopez-Fernandez, L. A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 88 - 88
  • [36] Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease
    Daryani, Nasser Ebrahimi
    Sadr, Maryam
    Soltani, Samaneh
    Saghazadeh, Amene
    Moossavi, Shirin
    Shahkarami, Sepideh
    Farhadi, Elham
    Rezaei, Nima
    DIGESTIVE DISEASES, 2019, 37 (01) : 21 - 32
  • [37] IL-16 levels are increased in patients with Crohn's disease and ulcerative colitis
    Seegert, D
    Rosenstiel, P
    Pfahler, H
    Folsch, UR
    Schreiber, S
    GASTROENTEROLOGY, 1999, 116 (04) : A816 - A817
  • [38] The Arg381gln SNP in IL23R does not influence response to immunomodulators in ulcerative colitis or Crohn's disease
    Baburajan, Bijay
    Prescott, Natalie
    Tremelling, Mark
    Cummings, Fraser
    Parkes, Miles
    Jewell, Derek P.
    Mathew, Christopher G.
    Marinaki, Anthony M.
    Sanderson, Jeremy D.
    GASTROENTEROLOGY, 2008, 134 (04) : A666 - A666
  • [39] Paraoxonase-1 Status in Crohn's Disease and Ulcerative Colitis
    Boehm, Dorota
    Krzystek-Korpacka, Malgorzata
    Neubauer, Katarzyna
    Matusiewicz, Molgorzato
    Berdowska, Lzabela
    Zielinski, Bogdan
    Paradowski, Leszek
    Gamian, Andrzej
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (01) : 93 - 99
  • [40] Immune Response and Gene Polymorphism Profiles in Crohn's Disease and Ulcerative Colitis
    Magalhaes Queiroz, Dulciene Maria
    Oliveira, Adriana Goncalves
    Borges Saraiva, Ivan Euclides
    Rocha, Gifone Aguiar
    Comargos Rocha, Andreia Mario
    Pimenta Sanna, Mario das Gracas
    Guerra, Juliano Becattini
    Dani, Renato
    Abreu Ferrari, Mario de Lourdes
    Fonseca Castro, Lucia Porto
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (03) : 353 - 358
12345